Integra LifeSciences Holdings Corporation
IART
$15.10
-$0.02-0.13%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -170.95% | 68.47% | 98.88% | -1,813.86% | -230.14% |
| Total Depreciation and Amortization | 0.00% | -0.24% | 2.20% | 1.36% | -16.78% |
| Total Amortization of Deferred Charges | -1.97% | -22.81% | -30.42% | 36.46% | -1.07% |
| Total Other Non-Cash Items | 153.12% | 40.66% | -103.78% | 402,841.88% | 104.18% |
| Change in Net Operating Assets | -99.52% | -163.17% | 234.75% | 26.86% | -105.67% |
| Cash from Operations | -17.04% | -71.11% | 358.64% | 179.23% | -122.19% |
| Capital Expenditure | 13.74% | -13.58% | 24.77% | 30.34% | 2.30% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -3,995.60% | 71.24% | 78.54% | -133.07% |
| Cash from Investing | 57.46% | -123.94% | 27.99% | 39.73% | -745.38% |
| Total Debt Issued | -10.46% | -91.77% | 4,579.84% | -76.29% | 53.67% |
| Total Debt Repaid | -41.86% | 95.91% | -3,762.72% | -4.22% | 61.84% |
| Issuance of Common Stock | -- | -- | -- | -100.00% | -- |
| Repurchase of Common Stock | -903.65% | 31.16% | 55.38% | 79.12% | 18.07% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -78.67% | 99.58% | -581.00% | -- |
| Cash from Financing | -65.91% | 337.60% | 51.54% | -159.75% | 594.78% |
| Foreign Exchange rate Adjustments | -192.55% | 301.12% | -106.32% | 179.93% | 155.76% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -38.47% | -79.95% | 167.35% | -191.43% | -123.29% |